PMID- 29065422 OWN - NLM STAT- MEDLINE DCOM- 20180727 LR - 20181113 IS - 1423-0224 (Electronic) IS - 0302-282X (Print) IS - 0302-282X (Linking) VI - 75 IP - 2 DP - 2017 TI - Acute Phencyclidine Alters Neural Oscillations Evoked by Tones in the Auditory Cortex of Rats. PG - 53-62 LID - 10.1159/000480511 [doi] AB - BACKGROUND/AIMS: The onset response to a single tone as measured by electroencephalography (EEG) is diminished in power and synchrony in schizophrenia. Because neural synchrony, particularly at gamma frequencies (30-80 Hz), is hypothesized to be supported by the N-methyl-D-aspartate receptor (NMDAr) system, we tested whether phencyclidine (PCP), an NMDAr antagonist, produced similar deficits to tone stimuli in rats. METHODS: Experiment 1 tested the effect of a PCP dose (1.0, 2.5, and 4.5 mg/kg) on response to single tones on intracranial EEG recorded over the auditory cortex in rats. Experiment 2 evaluated the effect of PCP after acute administration of saline or PCP (5 mg/kg), after continuous subchronic administration of saline or PCP (5 mg/kg/day), and after a week of drug cessation. In both experiments, a time-frequency analysis quantified mean power (MP) and phase locking factor (PLF) between 1 and 80 Hz. Event-related potentials (ERPs) were also measured to tones, and EEG spectral power in the absence of auditory stimuli. RESULTS: Acute PCP increased PLF and MP between 10 and 30 Hz, while decreasing MP and PLF between approximately 50 and 70 Hz. Acute PCP produced a dose-dependent broad-band increase in EEG power that extended into gamma range frequencies. There were no consistent effects of subchronic administration on gamma range activity. Acute PCP increased ERP amplitudes for the P16 and N70 components. CONCLUSIONS: Findings suggest that acute PCP-induced NMDAr hypofunction has differential effects on neural power and synchrony which vary with dose, time course of administration and EEG frequency. EEG synchrony and power appear to be sensitive translational biomarkers for disrupted NMDAr function, which may contribute to the pathophysiology of schizophrenia and other neuropsychiatric disorders. CI - (c) 2017 S. Karger AG, Basel. FAU - Schnakenberg Martin, Ashley M AU - Schnakenberg Martin AM AD - Department of Psychological and Brain Sciences, Indiana University-Bloomington, Bloomington, IN, USA. FAU - O'Donnell, Brian F AU - O'Donnell BF FAU - Millward, James B AU - Millward JB FAU - Vohs, Jenifer L AU - Vohs JL FAU - Leishman, Emma AU - Leishman E FAU - Bolbecker, Amanda R AU - Bolbecker AR FAU - Rass, Olga AU - Rass O FAU - Morzorati, Sandra L AU - Morzorati SL LA - eng GR - R21 MH071876/MH/NIMH NIH HHS/United States GR - T32 DA024628/DA/NIDA NIH HHS/United States PT - Journal Article DEP - 20171024 PL - Switzerland TA - Neuropsychobiology JT - Neuropsychobiology JID - 7512895 RN - 0 (Excitatory Amino Acid Antagonists) RN - J1DOI7UV76 (Phencyclidine) SB - IM MH - Acoustic Stimulation MH - Animals MH - Auditory Cortex/*drug effects MH - Dose-Response Relationship, Drug MH - Electroencephalography MH - Evoked Potentials, Auditory/*drug effects MH - Excitatory Amino Acid Antagonists/*pharmacology MH - Male MH - Phencyclidine/*pharmacology MH - Psychoacoustics MH - Rats MH - Rats, Sprague-Dawley MH - Spectrum Analysis MH - Time Factors PMC - PMC5752597 MID - NIHMS903971 OTO - NOTNLM OT - Auditory event-related potential OT - Neural synchrony OT - Phencyclidine OT - Rat model OT - Schizophrenia EDAT- 2017/10/25 06:00 MHDA- 2018/07/28 06:00 PMCR- 2018/10/24 CRDT- 2017/10/25 06:00 PHST- 2016/09/01 00:00 [received] PHST- 2017/08/21 00:00 [accepted] PHST- 2017/10/25 06:00 [pubmed] PHST- 2018/07/28 06:00 [medline] PHST- 2017/10/25 06:00 [entrez] PHST- 2018/10/24 00:00 [pmc-release] AID - 000480511 [pii] AID - 10.1159/000480511 [doi] PST - ppublish SO - Neuropsychobiology. 2017;75(2):53-62. doi: 10.1159/000480511. Epub 2017 Oct 24.